President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the federal government's Medicare program. The Centers for Medicare and ...

The Trump administration will not permit Medicare to pay for obesity drugs directly, declining on Friday to finalize a Biden-era proposal that would have allowed the federal health insurance program ...

The Trump administration will not permit Medicare to pay for obesity drugs directly, declining Friday to finalize a Biden-era proposal that would have allowed the federal health insurance program to ...

Medicare currently covers GLP-1 drugs such as Lilly's Mounjaro and Novo's Ozempic for diabetes. But under a CMS rule finalized Friday for Medicare plans, the proposal to expand coverage for weight ...

FILE - Donna Cooper holds up a dosage of Wegovy, a drug used for weight loss, at her home in Front Royal, Va., on Friday, March 1, 2024. (AP Photo/Amanda Andrade-Rhoades, File) ...

31,560 people played the daily Crossword recently. Can you solve it faster than others?31,560 people played the daily Crossword recently. Can you solve it faster than others?

Medicare and Medicaid will not cover blockbuster drugs such as Ozempic to treat obesity, the Trump administration announced on Friday. The Biden administration in November proposed allowing the ...